Additionally, investigating the broader implications of these mutations on AKT2 signaling pathways and their role in cancer progression could provide further insights into personalized therapeutic strategies and might pave the way for more effective and personalized treatment approaches for patients with AKT2 mutations. This evidence concerns the gene AKT2 and cancer.